Artemisinin

1. Lukinmaa S, Nakari UM, Liimatainen A, Siitonen A. Genomic diversity within phage types of Salmonella enterica ssp. enterica serotypes Enteritidis and Typhimurium. Foodborne Pathog Dis. 2006;3:97–105. http://dx.doi.org/10.1089/fpd.2006.3.97 2. Soyer Y, Moreno Switt A, Davis MA, Maurer J, McDonough PL, Schoonmaker-Bopp DJ, et al. Salmonella enterica serotype 4,5,12:I:-, an emerging Salmonella serotype that represents multiple distinct clones. J Clin Microbiol. 2009;47:3546–56. http://dx.doi. org/10.1128/JCM.00546-09 3. Sjölund-Karlsson M, Howie R, Krueger A, Rickert R, Pecic G, Lupoli K, et al. CTX-M–producing non-typhi Salmonella spp. isolated from humans, United States. Emerg Infect Dis. 2011;17:97–9. http://dx.doi.org/10.3201/eid1701.100511 4. Rodríguez I, Barownick W, Helmuth R, Mendoza MC, Rodicio MR, Schroeter A, et al. Extended-spectrum β-lactamases and AmpC β-lactamases in ceftiofur-resistant Salmonella enterica isolates from food and livestock obtained in Germany during 2003–07. J Antimicrob Chemother. 2009;64:301–9. http://dx.doi.org/10.1093/ jac/dkp195 5. EFSA Panel on Biological Hazards (BIOHAZ). Scientific opinion on the public health risks of bacterial strains producing extendedspectrum β-lactamases and/or AmpC β-lactamases in food and food-producing animals. EFSA Journal. 2011;9:2322. http://dx.doi. org/10.2903/j.efsa.2011.2322 6. Pitout JD, Laupland KB. Extended-spectrum beta-lactamaseproducing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8:159–66. http://dx.doi.org/10.1016/S14733099(08)70041-0 7. Nyberg SD, Österblad M, Hakanen AJ, Huovinen P, Jalava J; The Finnish Study Group for Antimicrobial Resistance. Detection and molecular genetics of extended-spectrum beta-lactamases among cefuroxime-resistant Escherichia coli and Klebsiella spp. isolates from Finland, 2002–2004. Scand J Infect Dis. 2007;39:417– 24. http://dx.doi.org/10.1080/00365540601105731 8. Hakanen A, Kotilainen P, Huovinen P, Helenius H, Siitonen A. Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerg Infect Dis. 2001;7:996–1003. http://dx.doi.org/10.3201/eid0706.010613 9. Lindgren MM, Kotilainen P, Huovinen P, Hurme S, Lukinmaa S, Webber MA, et al. Reduced fluoroquinolone susceptibility in Salmonella enterica isolates from travelers, Finland. Emerg Infect Dis. 2009;15:809–12. http://dx.doi.org/10.3201/eid1505.080849 10. Arlet G, Barrett TJ, Butaye P, Cloeckaert A, Mulvey MR, White DG. Salmonella resistant to extended-spectrum cephalosporins: prevalence and epidemiology. Microbes Infect. 2006;8:1945–54. http://dx.doi.org/10.1016/j.micinf.2005.12.029 11. CLSI. Performance standards for antimicrobial susceptibility testing: twentieth informational supplement. CLSI document M100– S20. Wayne (PA): Clinical Laboratory and Standards Institute; 2010. 12. Jones CH, Ruzin A, Tuckman M, Visalli MA, Petersen PJ, Bradford PA. Pyrosequencing using the single-nucleotide polymorphism protocol for rapid determination of TEMand SHV-type extended-spectrum β-lactamases in clinical isolates and identification of the novel β-lactamase genes blaSHV-48, blaSHV-105, and blaTEM-155. Antimicrob Agents Chemother. 2009;53:977–86. http://dx.doi. org/10.1128/AAC.01155-08 13. Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol. 2002;40:2153–62. http://dx.doi.org/10.1128/ JCM.40.6.2153-2162.2002 14. Gunell M, Webber MA, Kotilainen P, Lilly AJ, Caddick JM, Jalava J, et al. Mechanisms of resistance in nontyphoidal Salmonella enterica strains exhibiting a nonclassical quinolone resistance phenotype. Antimicrob Agents Chemother. 2009;53:3832–6. http://dx.doi.org/10.1128/AAC.00121-09 15. Tham J, Odenholt I, Walder M, Brolund A, Ahl J, Melander E. Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers’ diarrhoea. Scand J Infect Dis. 2010;42:275– 80. http://dx.doi.org/10.3109/00365540903493715